> ## Content Index
> Fetch the complete content index at: https://www.coios.me/llms.txt
> Use this file to discover other available public pages before exploring further.

# Measles outbreak in England from 2023 to 2024 concentrated in children and deprived areas
- URL: https://www.coios.me/measles-outbreak-in-england-from-2023-to-2024-concentrated/
- Published: 2026-11-15T11:37:55.000Z
- Updated: 2026-11-15T12:16:00.000Z
- Description: England's largest measles outbreak in decades had 2,821 laboratory-confirmed cases, 92.5% unvaccinated and 63.0% in the two most deprived quintiles.
- Author: Daniel Ryan
- Tags: Behavioural science, Infection and pandemics, What linked data reveals, Changing behaviour at scale, United Kingdom, #peer-reviewed, #refines, #item, #source-2026-11, #score-72

UKHSA describes England's largest measles outbreak in decades, from October 2023 to September 2024\. A line list combined notification, laboratory, demographic and vaccination data, linked to emergency and hospital records. Of 2,821 laboratory-confirmed cases, 45.5% lived in London and 58.6% were children under 10\. Overall, 92.5% of cases were unvaccinated and 63.0% lived in the two most deprived quintiles. Of 2,788 linked cases, 76.3% attended emergency care, 38.2% were admitted, seven needed intensive care and one died. The abstract states no limitations.

*Why it is interesting: Admission was most common in infants under one (51.6%) and adults aged 30 or over (47.2%). The authors describe the outbreak as a shift towards endemic transmission in areas of high deprivation and low vaccine uptake.*

Source

[Eurosurveillance, 12 November 2026](https://doi.org/10.2807/1560-7917.es.2026.31.45.2600124?ref=coios.me)

Paper

Measles resurgence in England: challenges in maintaining elimination, 2023 to 2024

Authors

Hani E, Venkatraman T, Stowe J, Cordery R, Ramsay M, Saliba V

DOI

10.2807/1560-7917.es.2026.31.45.2600124

Type

Peer-reviewed article

Design

National enhanced surveillance line list of 2,821 laboratory-confirmed measles cases, England, October 2023 to September 2024, linked to emergency and admission records

Verdict

Refines prior evidence

Driver

[Infection and pandemics](https://www.coios.me/d-infectious-disease/)

Driver

[What linked data reveals](https://www.coios.me/d-linked-data/)

Driver

[Changing behaviour at scale](https://www.coios.me/d-behaviour-change/)

Abstract — the authors' own words, CC BY

BACKGROUNDBetween October 2023 and September 2024, England experienced the largest measles outbreak in decades.AIMWe describe the epidemiology of the outbreak, burden on secondary care services and the factors that led to this resurgence.METHODSThe UK Health Security Agency (UKHSA) conducts enhanced surveillance of all suspected measles cases in England. A measles line list was established using routinely collected notification, laboratory, demographic and vaccination information. Laboratory-confirmed cases were defined using serology and PCR. Incidence rates were calculated using mid-2024 population estimates. Severity was assessed through linkage with emergency department attendances, hospital admissions and length of stay.RESULTSMost of the 2,821 laboratory-confirmed cases resided in London (n = 1,283; 45.5%) and in the West Midlands (n = 710; 25.2%). Incidence was highest in London (14.1/100,000 population). Children under 10 years represented 58.6% (n = 1,653) of cases. Most cases (n = 2,609; 92.5%) were not vaccinated, and 63.0% (n = 1,776) lived in areas belonging to the two most deprived quintiles. Of the 2,788 cases that could be linked to hospitalisation data, 76.3% (n = 2,127) attended emergency care and 38.2% (n = 1,066) were admitted. Median length of stay was 2.0 days, seven cases received intensive care; one death was reported. Admissions were highest among infants aged < 1 year (51.6%, 165/320) and adults ≥ 30 years (47.2%, 195/413).CONCLUSIONThis outbreak reflects a shift towards endemic measles transmission in areas of high deprivation and low vaccine uptake in England. It underscores the importance of achieving 95% uptake with measles vaccine in all areas and communities to achieve and maintain elimination.